{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:35Z","timestamp":1787020835489,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To analyze whether ANA-positive idiopathic anterior uveitis differs from JIA-associated uveitis concerning clinical course, response to treatment, and disease outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective study of the National Paediatric Rheumatological Database (NPRD) including its uveitis add-on module from the years 2002 to 2016. Cross-sectional data from the years 2002 to 2016 were analyzed. Patients with JIA-associated uveitis and with ANA-positive idiopathic anterior uveitis were included and the disease manifestation investigated in terms of uveitis characteristics and disease course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the total cohort of 34,458 patients enrolled in the NPRD, including 3551 patients with uveitis, those with detailed uveitis documentation were taken into account: 62 ANA-positive patients with idiopathic anterior uveitis (group 1), 688 patients with initial uveitis diagnosis after JIA onset (group 2), and 61 JIA patients with initial uveitis diagnosis before arthritis onset (group 3). Anterior uveitis was documented in 100%, 94%, and 80% of patients and with insidious onset of uveitis flare in 50%, 70.9%, and 56.1% each in groups 1, 2, and 3, respectively. Use of topical or systemic corticosteroids and conventional synthetic or biological DMARDs did not significantly differ between the patient groups, either at the initial or the 2-year follow-up (2-FU) visits (mean 2\u2009years, each\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). At 2-FU, uveitis inactivity was achieved in 64.7%, 55.8%, and 61.5% of patients in groups 1, 2, and 3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). Uveitis-related complications were more frequent at the initial visit and at 2-FU in groups 1 and 3, as compared to group 2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ANA-positive idiopathic uveitis and JIA-associated uveitis do not significantly differ concerning clinical course of uveitis, treatment, and response to corticosteroids and DMARDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02166-3","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T09:03:53Z","timestamp":1586941433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany"],"prefix":"10.1186","volume":"22","author":[{"given":"Arnd","family":"Heiligenhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Klotsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Niewerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"2166_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"2166_CR2","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson G\u00e4re B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30:2275\u201382.","journal-title":"J Rheumatol"},{"key":"2166_CR3","first-page":"1377","volume":"33","author":"S Danner","year":"2006","unstructured":"Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M, et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol. 2006;33:1377\u201381.","journal-title":"J Rheumatol"},{"key":"2166_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3109\/03009741003742722","volume":"39","author":"C Modesto","year":"2010","unstructured":"Modesto C, Ant\u00f3n J, Rodriguez B, Bou R, Arnal C, Ros J, et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol. 2010;39:472\u20139.","journal-title":"Scand J Rheumatol"},{"key":"2166_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","volume":"244","author":"PE Carvounis","year":"2006","unstructured":"Carvounis PE, Herman DC, Cha S, Burke JP. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol. 2006;244:281\u201390.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2166_CR6","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K, German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007;46:1015\u20131019.","DOI":"10.1093\/rheumatology\/kem053"},{"key":"2166_CR7","first-page":"394","volume":"30","author":"SL Bowyer","year":"2003","unstructured":"Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, et al. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 2003;30:394\u2013400.","journal-title":"J Rheumatol"},{"key":"2166_CR8","first-page":"936","volume":"33","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A. Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis: data from a cross-sectional analysis of a prospective nationwide study. Clin Exp Rheumatol. 2015;33:936\u201344.","journal-title":"Clin Exp Rheumatol"},{"key":"2166_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840\u20136.","journal-title":"Am J Ophthalmol"},{"key":"2166_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0161-6420(97)30329-7","volume":"10482","author":"MR Dana","year":"1997","unstructured":"Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;10482:236\u201344.","journal-title":"Ophthalmology"},{"key":"2166_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/bjo.87.7.879","volume":"87","author":"J de Boer","year":"2003","unstructured":"de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879\u201384.","journal-title":"Br J Ophthalmol"},{"key":"2166_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.22381","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 2007;56:647\u201357.","journal-title":"Arthritis Rheum"},{"key":"2166_CR13","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3899\/jrheum.130302","volume":"40","author":"ST Angeles-Han","year":"2013","unstructured":"Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, et al. Risk markers of juvenile idiopathic arthritis-associated uveitis in the childhood arthritis and rheumatology research Alliance (CARRA) registry. J Rheumatol. 2013;40:2088\u201396.","journal-title":"J Rheumatol"},{"key":"2166_CR14","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/art.40544","volume":"70","author":"C Tappeiner","year":"2018","unstructured":"Tappeiner C, Klotsche J, Sengler C, Niewerth M, Liedmann I, Walscheid K, et al. Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study. Arthritis Rheumatol. 2018;70:1685\u201394.","journal-title":"Arthritis Rheumatol"},{"key":"2166_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","volume":"35","author":"R Bou","year":"2015","unstructured":"Bou R, Adan A, Borras F, Bravo B, Calvo I, De Inocencio J, et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int. 2015;35:777\u201385.","journal-title":"Rheumatol Int"},{"key":"2166_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semarthrit.2018.11.004","volume":"49","author":"A Heiligenhaus","year":"2019","unstructured":"Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C, et al. Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum. 2019;49:43\u201355.","journal-title":"Semin Arthritis Rheum"},{"key":"2166_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acr.22649","volume":"68","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J. Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database. Arthritis Care Res (Hoboken). 2016;68:46\u201354.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2166_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/key406","volume":"58","author":"A Heiligenhaus","year":"2019","unstructured":"Heiligenhaus A, Klotsche J, Tappeiner C, Sengler C, Niewerth M, Liedmann I, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study. Rheumatology (Oxford). 2019;58:975\u201386.","journal-title":"Rheumatology (Oxford)"},{"key":"2166_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376:1637\u201346.","journal-title":"N Engl J Med"},{"key":"2166_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/acr.23610","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, et al. Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken). 2019;71:482\u201391.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2166_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ajo.2008.11.009","volume":"147","author":"GN Holland","year":"2009","unstructured":"Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am J Ophthalmol. 2009;147:667\u201378.","journal-title":"Am J Ophthalmol"},{"key":"2166_CR22","first-page":"622","volume":"29","author":"K Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J, Zink A, German Study Group of Pediatric Rheumatologists. Health care provision in pediatric rheumatology in Germany--national rheumatologic database. J Rheumatol. 2002;29:622\u20138.","journal-title":"J Rheumatol"},{"key":"2166_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"2166_CR24","first-page":"1107","volume":"77","author":"T Constantin","year":"2018","unstructured":"Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77:1107\u201317.","journal-title":"Ann Rheum Dis"},{"key":"2166_CR25","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0161-6420(01)00773-4","volume":"108","author":"K Kotaniemi","year":"2001","unstructured":"Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001;108:2071\u20135.","journal-title":"Ophthalmology"},{"key":"2166_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ajo.2014.11.007","volume":"159","author":"AJ Haasnoot","year":"2015","unstructured":"Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, Schalij-Delfos NE, Los LI, Armbrust W, et al. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol. 2015;159:372\u20137.","journal-title":"Am J Ophthalmol"},{"key":"2166_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0002-9394(03)00225-3","volume":"135","author":"A Chia","year":"2003","unstructured":"Chia A, Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol. 2003;135:757\u201362.","journal-title":"Am J Ophthalmol"},{"key":"2166_CR28","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","volume":"111","author":"KD Rosenberg","year":"2004","unstructured":"Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111:2299\u2013306.","journal-title":"Ophthalmology"},{"key":"2166_CR29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3109\/09273948.2013.815785","volume":"21","author":"AT Vitale","year":"2013","unstructured":"Vitale AT, Graham E, de Boer JH. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm. 2013;21:478\u201385.","journal-title":"Ocul Immunol Inflamm"},{"key":"2166_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","volume":"14","author":"LA Henderson","year":"2016","unstructured":"Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS, et al. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatr Rheumatol Online J. 2016;14:9.","journal-title":"Pediatr Rheumatol Online J"},{"key":"2166_CR31","first-page":"119","volume":"17","author":"K Kotaniemi","year":"1999","unstructured":"Kotaniemi K, Kaipiainen-Sepp\u00e4nen O, Savolainen A, Karma A. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1999;17:119\u201322.","journal-title":"Clin Exp Rheumatol"},{"key":"2166_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12969-018-0266-5","volume":"16","author":"M Cann","year":"2018","unstructured":"Cann M, Ramanan AV, Crawford A, Dick AD, Clarke SLN, Rashed F, et al. Outcomes of non-infectious paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol Online J. 2018;16:51.","journal-title":"Pediatr Rheumatol Online J"},{"key":"2166_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658\u201366.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02166-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02166-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02166-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T04:12:01Z","timestamp":1680063121000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02166-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02166-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"25 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Charit\u00e9 University Medicine Berlin and by the local Ethics Committees, as required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AH has received research grants from BMBF (FKZ,01ER1504C), Pfizer, and Novartis and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. JK, none. MN, none. GH has received research grants from AbbVvie, Chugai, Pfizer, MSD Sharp and Dohme, Novartis and Roche and honoraria from AbbVie, Bayer, MSD Sharp and Dohme, Pfizer and Novartis. GG, none. JPH, none. KM is funded by the Deutsche Rheumastiftung and has received honoraria from AbbVie, Biermann, gsk, Medac, and Sanofi.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}